SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-053085
Filing Date
2018-02-22
Accepted
2018-02-22 07:18:05
Documents
5
Period of Report
2018-02-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d527765d8k.htm 8-K 28888
2 EX-99.1 d527765dex991.htm EX-99.1 50813
3 EX-99.2 d527765dex992.htm EX-99.2 18855
4 GRAPHIC g527765g0222062015754.jpg GRAPHIC 3674
5 GRAPHIC g527765g0222062015832.jpg GRAPHIC 4393
  Complete submission text file 0001193125-18-053085.txt   111365
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 18630559
SIC: 2836 Biological Products, (No Diagnostic Substances)